Filing Flows › Sanara MedTech (SMTI) › Q1 2026 › vs Q1 2025
Sanara MedTech (SMTI) Q1 2026 vs Q1 2025 (year over year)
Sanara MedTech's revenue rose $4.4M (+19%) from $23.4M in Q1 2025 to $27.8M in Q1 2026. The biggest changes: Soft Tissue Repair Products +$4.4M (+21%); Bone Fusion Products −$46K (-2%). Gross margin 93.1% against 92.2% (+0.9 pts).
Sanara MedTech, Q1 2026: revenue $27.8M (+19% year over year), operating margin 9.5%, net earnings $459K, operating cash flow −$2.5M. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 93.1% | 92.2% | +0.9 pts |
| Operating margin | 9.5% | 3.5% | +6.0 pts |
| Net margin | 1.6% | -15.1% | +16.7 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Soft Tissue Repair Products | $24.9M | $20.5M | $4.4M | +21% |
| Bone Fusion Products | $2.9M | $2.9M | −$46K | -2% |
| Revenue | $27.8M | $23.4M | $4.4M | +19% |
| Gross profit | $25.9M | $21.6M | $4.3M | +20% |
| Cost of revenue | $1.9M | $1.8M | $89K | +5% |
| Operating profit | $2.6M | $826K | $1.8M | +221% |
| Operating expenses | $23.2M | $20.8M | $2.5M | +12% |
| Pre-tax earnings | $459K | −$3.5M | $4.0M | — |
| Other expense, net | $2.2M | $4.4M | −$2.2M | -50% |
| Research & development | $760K | $950K | −$191K | -20% |
| Sales & marketing | $17.0M | $15.1M | $1.9M | +13% |
| General & admin | $4.9M | $4.0M | $829K | +21% |
| Other operating costs | $587K | $694K | −$107K | -15% |
| Net earnings | $459K | −$3.5M | $4.0M | — |
| Operating cash sources | $4.5M | $901K | $3.6M | +404% |
| Depreciation & amortization | $587K | $1.1M | −$537K | -48% |
| Share-based compensation | $1.0M | $1.3M | −$277K | -21% |
| Cash used in operations | $2.5M | $2.0M | $467K | +23% |
| Working capital & other | $4.5M | $901K | $3.6M | +404% |
Questions
How much did Sanara MedTech's revenue grow year over year in Q1 2026?
Sanara MedTech's revenue rose $4.4M (+19%) from $23.4M in Q1 2025 to $27.8M in Q1 2026.
What drove Sanara MedTech's revenue change in Q1 2026?
Soft Tissue Repair Products +$4.4M (+21%); Bone Fusion Products −$46K (-2%).